Grown Rogue International (GRUSF) Liabilities and Shareholders Equity (2009 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Liabilities and Shareholders Equity of $65.8 million in Q1 2026, up 4.95% quarter-over-quarter from $62.7 million in Q4 2025.
Grown Rogue International (GRUSF) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Grown Rogue International's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $65.8 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $65.8 million; the TTM figure through Mar 2026 stood at $55902.6 billion (up 53711927.42% YoY), while the FY2025 annual figure was $62.7 million, changed N/A from the prior year.
- Liabilities and Shareholders Equity was $65.8 million for Q1 2026 at Grown Rogue International, up from $62.7 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $55902.5 billion in Q3 2025 to a low of $18.8 million in Q1 2023.
- Historically, Liabilities and Shareholders Equity has averaged $6211.4 billion across 4 years, with a median of $38.7 million in 2024.
- Biggest YoY gain for Liabilities and Shareholders Equity was 184514363.33% in 2025; the steepest drop was 37.47% in 2025.
- A 4-year view of Liabilities and Shareholders Equity shows it stood at $21.8 million in 2023, then soared by 109.79% to $45.6 million in 2024, then surged by 37.47% to $62.7 million in 2025, then increased by 4.95% to $65.8 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $65.8 million (Q1 2026), $62.7 million (Q4 2025), and $55902.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.04 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.15 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.71 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 555.95 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.91 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.22 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.26 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.27 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.35 Bn |
| 10 | Grown Rogue International | - | - | 3.96 Mn | 65.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.84 Mn |
| Dec 31, 2025 | 62.74 Mn |
| Sep 30, 2025 | 55,902.47 Bn |
| Dec 31, 2024 | 45.64 Mn |
| Sep 30, 2024 | 30.30 Mn |
| Jun 30, 2024 | 28.14 Mn |
| Mar 31, 2024 | 38.70 Mn |
| Dec 31, 2023 | 21.75 Mn |
| Jan 31, 2023 | 18.78 Mn |
| Apr 30, 2021 | 8.69 Mn |
| Jan 31, 2021 | 5.71 Mn |
| Oct 31, 2020 | 3.76 Mn |
| Apr 30, 2020 | 3.80 Mn |
| Jan 31, 2020 | 3.17 Mn |
| Oct 31, 2019 | 2.93 Mn |
| Jan 31, 2019 | 6.52 Mn |
| Oct 31, 2018 | 5.37 Mn |
| Aug 31, 2018 | 25,236.92 |
| May 31, 2018 | 11.02 Bn |
| Feb 28, 2018 | 21,723.15 |